Literature DB >> 16405877

Structure and function of matrix metalloproteinases and TIMPs.

Hideaki Nagase1, Robert Visse, Gillian Murphy.   

Abstract

Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers. They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs). This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiology and pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405877     DOI: 10.1016/j.cardiores.2005.12.002

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  919 in total

1.  Assessment of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis.

Authors:  Josefine Hirschfeld; Mohammed Howait; Alexandru Movila; Marijo Parčina; Isabelle Bekeredjian-Ding; James Deschner; Søren Jepsen; Toshihisa Kawai
Journal:  Eur J Oral Sci       Date:  2017-08-04       Impact factor: 2.612

2.  Endoplasmic reticulum oxidase 1α is critical for collagen secretion from and membrane type 1-matrix metalloproteinase levels in hepatic stellate cells.

Authors:  Mizuki Fujii; Akihiro Yoneda; Norio Takei; Kaori Sakai-Sawada; Marina Kosaka; Kenjiro Minomi; Atsuro Yokoyama; Yasuaki Tamura
Journal:  J Biol Chem       Date:  2017-08-03       Impact factor: 5.157

Review 3.  Targeting collagen expression in alcoholic liver disease.

Authors:  Kyle J Thompson; Iain H McKillop; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

4.  Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury.

Authors:  Rupak Mukherjee; Gregory P Colbath; Charles D Justus; James A Bruce; Claire M Allen; Kenneth W Hewett; J Philip Saul; Robert G Gourdie; Francis G Spinale
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

5.  Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).

Authors:  Marie Kveiborg; Jonas Jacobsen; Meng-Huee Lee; Hideaki Nagase; Ulla M Wewer; Gillian Murphy
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

Review 6.  ECM roles in the function of metabolic tissues.

Authors:  Guorui Huang; Daniel S Greenspan
Journal:  Trends Endocrinol Metab       Date:  2011-11-08       Impact factor: 12.015

Review 7.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 8.  MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.

Authors:  Yongqi Li; Weicheng Wang; Lei Li; Raouf A Khalil
Journal:  Life Sci       Date:  2020-04-10       Impact factor: 5.037

9.  Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.

Authors:  Luis A Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; Leonardo Gonnelli
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

10.  Minocycline attenuates cardiac dysfunction in tumor-burdened mice.

Authors:  Raymond D Devine; Clayton M Eichenseer; Loren E Wold
Journal:  J Mol Cell Cardiol       Date:  2016-09-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.